Filing Details
- Accession Number:
- 0001179110-18-011636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-25 10:55:49
- Reporting Period:
- 2018-09-20
- Accepted Time:
- 2018-09-25 10:55:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726419 | Stephany Verstraete | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-20 | 12,000 | $17.99 | 13,925 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-09-20 | 6,000 | $17.99 | 19,925 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-20 | 12,000 | $74.52 | 7,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-09-20 | 6,000 | $75.32 | 1,925 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-09-20 | 12,000 | $0.00 | 12,000 | $17.99 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-09-20 | 6,000 | $0.00 | 6,000 | $17.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 119,000 | 2026-01-04 | No | 4 | M | Direct | |
| 113,000 | 2026-01-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 20, 2018.
- Represents the weighted average price of transactions ranging from $74.00 to $75.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average price of transactions ranging from $75.00 to $75.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option vests as to 25% of the shares on January 4, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
